SUBSCRIBE
SUBSCRIBE

Preclinical

Bookmark and Share
Drug Development
Nanofiber Gel May Spur Growth of New Knee Cartilage, Northwestern University Study
February 5, 2010
 · 
1 min read
Bookmark and Share
Drug Development
Umbilical Cord Blood Stem Cell Transplant May Help Lung, Heart Disorders, Samsung Medical Center Study
November 30, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Stem Cells: Cincinnati Children’s Hospital Medical Center Scientists Successfully Reprogram Blood Cells
November 12, 2009
 · 
1 min read
Drug Development
Developmental Drug May Help Bone Fractures Heal After Radiation Exposure, University of Pittsburgh School of Medicine Study
November 3, 2009
 · 
1 min read
Drug Development
Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers, University of Cincinnati and Leiden University Medical Center Study
November 2, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Drug-radiation Combo Eradicates Lung Cancer In Mice, UT Southwestern Medical Center Study
October 30, 2009
 · 
1 min read
Drug Development
Nervous System Drug-by-design: Formulation May Slow Parkinson’s, Alzheimer’s, Huntington’s, Tel Aviv University Study
October 27, 2009
 · 
1 min read
Drug Development
Cocaine Exposure During Pregnancy Leads To Impulsivity In Male, Not Female, Monkeys, Wake Forest University School of Medicine Study
October 26, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Dogs Aid In Advancing Human Cancer Therapy, National Cancer Institute Scientists Say
October 14, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Paralyzed Rats Walk Again, University of California, Los Angeles (UCLA) Scientist Use Drug-Electricity Combo to Make Paralyzed Rats Sprint
September 21, 2009
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 23, 2025
 · 
3 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
 · 
3 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 18, 2025
 · 
2 min read
Press Releases
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
December 18, 2025
 · 
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
 · 
4 min read
Press Releases
Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury
December 16, 2025
 · 
4 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
 · 
6 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
 · 
2 min read
Press Releases
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
December 12, 2025
 · 
5 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
December 12, 2025
 · 
6 min read
Press Releases
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
December 11, 2025
 · 
5 min read
Press Releases
MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation
December 11, 2025
 · 
2 min read
Press Releases
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
December 11, 2025
 · 
7 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
December 10, 2025
 · 
4 min read
Press Releases
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
December 10, 2025
 · 
7 min read
Press Releases
Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer
December 10, 2025
 · 
8 min read
Press Releases
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
December 10, 2025
 · 
2 min read
Load More